Articles published by Incyte and Escient Pharmaceuticals
Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
April 23, 2024
From
Incyte and Escient Pharmaceuticals
Via
Business Wire
Tickers
INCY
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.